AMRN Competitors
Amarin Corporation plc
$11.71
-$0.04(-0.34%)
40
Overall
60
Value
10
Tech
52
Quality
Market Cap
$242.45M
Volume
81.27K
52W Range
$11.25 - $17.31
Target Price
$12.67
AMRN competitors: ABBV, TEVA, ALKS, GSK, AZN. Amarin Corporation plc is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
AMRN Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| ABBV AbbVie Inc. | $293.86 | $519.48B | $13.98 | 2.35% | 61 |
| TEVA Teva Pharmaceutical Industries Limited | $43.11 | $49.47B | $1.94 | - | 61 |
| ALKS Alkermes plc | $47.42 | $7.81B | $-0.56 | 2.26% | 61 |
| GSK GSK plc | $50.47 | $103.52B | $4.78 | 3.60% | 42 |
| AZN AstraZeneca PLC | $184.89 | $287.39B | $10.22 | 1.29% | 75 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMRN | $11.71 | -0.3% | 81.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |